Cetera Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.67M	Buy	23,173 +5,624	+32%	+$1.91M	0.01%	1233
2025 Q4	$6.98M	Buy	17,549 +3,026	+21%	+$1.34M	0.01%	1243
2025 Q3	$6.62M	Buy	14,523 +4,635	+47%	+$1.89M	0.01%	1215
2025 Q2	$3.22M	Buy	9,888 +1,871	+23%	+$518K	0.01%	1495
2025 Q1	$2.16M	Buy	8,017 +3,247	+68%	+$834K	﹤0.01%	1693
2024 Q4	$1.12M	Buy	4,770 +1,902	+66%	+$500K	﹤0.01%	2086
2024 Q3	$789K	Buy	2,868 +129	+5%	+$33.6K	﹤0.01%	2290
2024 Q2	$666K	Sell	2,739 -819	-23%	-$129K	﹤0.01%	2375
2024 Q1	$532K	Buy	3,558 +2,388	+204%	+$398K	﹤0.01%	2558
2023 Q4	$224K	Buy	+1,170	New	+$199K	﹤0.01%	1977
2023 Q2	–	Sell	-1,187	Closed	-$238K	–	2196
2023 Q1	$238K	Buy	1,187 +24	+2%	+$5.04K	﹤0.01%	1839
2022 Q4	$276K	Buy	+1,163	New	+$248K	﹤0.01%	1715
2022 Q1	–	Sell	-1,217	Closed	-$206K	–	1873
2021 Q4	$206K	Buy	+1,217	New	+$226K	﹤0.01%	1721